Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDNovoCure Ltd Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$0.70 | -$0.33 | -$0.49 |
| Q2 2026 | 5 | -$0.51 | -$0.28 | -$0.37 |
| Q3 2026 | 1 | -$0.35 | -$0.32 | -$0.34 |
| Q4 2026 | 1 | -$0.33 | -$0.31 | -$0.32 |
| Q1 2027 | 1 | -$0.34 | -$0.31 | -$0.32 |
| Q2 2027 | 1 | -$0.32 | -$0.29 | -$0.31 |
| Q3 2027 | 1 | -$0.28 | -$0.26 | -$0.27 |
| Q4 2027 | 1 | -$0.28 | -$0.26 | -$0.27 |
NovoCure Ltd Earnings Date And Information
NovoCure Ltd last posted its earnings results on Thursday, February 26th, 2026. The company reported $-0.22 earnings per share for the quarter, topping analysts' consensus estimates of $-0.41 by $0.19. The company had revenue of 174.35 M for the quarter and had revenue of 655.35 M for the year. NovoCure Ltd has generated $-1 earnings per share over the last year ($-1.22 diluted earnings per share) and currently has a price-to-earnings ratio of -11.19. NovoCure Ltd has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
NovoCure Ltd Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 2025 | -$0.41 | -$0.22 | 0.19 | $174.40 M | $174.35 M |
| 10/30/2025 | Q3 2025 | -$0.42 | -$0.33 | 0.09 | $158.94 M | $167.20 M |
| 07/24/2025 | Q2 2025 | -$0.39 | -$0.36 | 0.03 | $154.16 M | $158.81 M |
| 04/24/2025 | Q1 2025 | -$0.47 | -$0.31 | 0.16 | $146.94 M | $154.99 M |
| 02/27/2025 | Q4 2024 | -$0.34 | -$0.61 | -0.27 | $161.30 M | $161.27 M |
| 10/30/2024 | Q3 2024 | -$0.34 | -$0.28 | 0.06 | $143.95 M | $155.10 M |
| 07/25/2024 | Q2 2024 | -$0.40 | -$0.31 | 0.09 | $135.83 M | $150.36 M |
| 05/02/2024 | Q1 2024 | -$0.43 | -$0.36 | 0.07 | $131.44 M | $138.50 M |
| 02/22/2024 | Q4 2023 | -$0.53 | -$0.44 | 0.09 | N/A | $133.78 M |
| 10/26/2023 | Q3 2023 | -$0.52 | -$0.46 | 0.06 | N/A | $127.32 M |
| 07/27/2023 | Q2 2023 | -$0.50 | -$0.54 | -0.04 | N/A | $126.05 M |
| 05/04/2023 | Q1 2023 | -$0.36 | -$0.50 | -0.14 | N/A | $122.18 M |
| 02/23/2023 | Q4 2022 | -$0.32 | -$0.36 | -0.04 | N/A | $128.43 M |
| 10/27/2022 | Q3 2022 | -$0.30 | -$0.25 | 0.05 | N/A | $131.00 M |
| 07/28/2022 | Q2 2022 | -$0.14 | -$0.23 | -0.09 | N/A | $140.87 M |
| 04/28/2022 | Q1 2022 | -$0.17 | -$0.04 | 0.13 | N/A | $137.55 M |
| 02/24/2022 | Q4 2021 | -$0.10 | -$0.25 | -0.15 | N/A | $133.21 M |
| 10/28/2021 | Q3 2021 | -$0.06 | -$0.13 | -0.07 | N/A | $133.61 M |
| 07/29/2021 | Q2 2021 | -$0.01 | -$0.14 | -0.13 | N/A | $133.52 M |
| 04/29/2021 | Q1 2021 | -$0.01 | -$0.04 | -0.03 | N/A | $134.70 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NovoCure Ltd Earnings: FAQ's
In the previous quarter, NovoCure Ltd (:NVCR) reported $-0.22 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.41 by $0.19.
The conference call for NovoCure Ltd's latest earnings report can be listened to online.
The conference call transcript for NovoCure Ltd's latest earnings report can be read online.
NovoCure Ltd (:NVCR) has a recorded annual revenue of $655.35 M.
NovoCure Ltd (:NVCR) has a recorded net income of $-136,227,000.NovoCure Ltd has generated $-1.22 earnings per share over the last four quarters.
NovoCure Ltd (:NVCR) has a price-to-earnings ratio of -11.19 and price/earnings-to-growth ratio is -0.46.